Literature DB >> 31816024

Association Between Breastfeeding and Postpartum Multiple Sclerosis Relapses: A Systematic Review and Meta-analysis.

Kristen M Krysko1, Alice Rutatangwa1, Jennifer Graves1,2, Ann Lazar3, Emmanuelle Waubant1.   

Abstract

Importance: Multiple sclerosis (MS) relapses may be increased in the postpartum period, and whether breastfeeding is associated with reduction in the risk of postpartum relapses remains controversial. Objective: To perform a systematic review and meta-analysis to evaluate whether breastfeeding is associated with reduction in postpartum MS relapses compared with not breastfeeding. Data Sources: PubMed and Embase were searched for studies assessing the association between breastfeeding and MS disease activity published between January 1, 1980, and July 11, 2018, as well as reference lists of selected articles. Study Selection: All study designs assessing the association between breastfeeding and postpartum relapses in MS relative to a comparator group were included. Data Extraction and Synthesis: Study eligibility assessment and extraction of study characteristics, methods, and outcomes, were performed independently by 2 reviewers following PRISMA guidelines. Risk of bias was evaluated by 2 independent reviewers with the ROBINS-I tool for nonrandomized, interventional studies. Findings from studies with data available for the number of women with postpartum relapses in the breastfeeding and nonbreastfeeding groups were combined with a random-effects model. Main Outcomes and Measures: Postpartum MS relapse.
Results: The search identified 462 unique citations, and 24 (2974 women) satisfied eligibility criteria and were included, of which 16 were included in the quantitative meta-analysis. The pooled summary odds ratio for the association of breastfeeding with postpartum relapses was 0.63 (95% CI, 0.45-0.88; P = .006) compared with a reference of nonbreastfeeding. Pooled adjusted hazard ratio across 4 studies that reported this finding was 0.57 (95% CI, 0.38-0.85; P = .006). There was moderate heterogeneity (I2 = 48%), which was explained by variable prepregnancy relapse rate, postpartum follow-up duration, and the publication year. A stronger association was seen in studies of exclusive rather than nonexclusive breastfeeding, although both demonstrated an association. Studies were rated at moderate and serious risk of bias, with concern for residual confounding, although sensitivity analysis including only moderate quality studies was consistent with a protective outcome of breastfeeding. Conclusions and Relevance: These findings suggest that breastfeeding is protective against postpartum relapses in MS, although high-quality prospective studies to date are limited and well-designed observational studies that aim to emulate a randomized trial would be of benefit.

Entities:  

Year:  2020        PMID: 31816024      PMCID: PMC6902174          DOI: 10.1001/jamaneurol.2019.4173

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  35 in total

1.  Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.

Authors:  L Airas; A Jalkanen; A Alanen; T Pirttilä; R J Marttila
Journal:  Neurology       Date:  2010-08-03       Impact factor: 9.910

2.  Protective effect of breastfeeding in postpartum relapse rate of mothers with multiple sclerosis.

Authors:  Kerstin Hellwig; Aiden Haghikia; Heike Agne; Christian Beste; Ralf Gold
Journal:  Arch Neurol       Date:  2009-12

3.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

4.  History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort.

Authors:  Amandine Benoit; Françoise Durand-Dubief; Maria-Pia Amato; Emilio Portaccio; Romain Casey; Stéphanie Roggerone; Géraldine Androdias; Laurence Gignoux; Iuliana Ionescu; Maria-Giovanna Marrosu; Eleonora Cocco; Angelo Ghezzi; Pietro Annovazzi; Maria Trojano; Marta Simone; Romain Marignier; Christian Confavreux; Sandra Vukusic
Journal:  Neurology       Date:  2016-07-27       Impact factor: 9.910

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding.

Authors:  L M Nelson; G M Franklin; M C Jones
Journal:  JAMA       Date:  1988-06-17       Impact factor: 56.272

7.  Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.

Authors:  C Confavreux; M Hutchinson; M M Hours; P Cortinovis-Tourniaire; T Moreau
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

8.  Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.

Authors:  Sandra Vukusic; Michael Hutchinson; Martine Hours; Thibault Moreau; Patricia Cortinovis-Tourniaire; Patrice Adeleine; Christian Confavreux
Journal:  Brain       Date:  2004-05-06       Impact factor: 13.501

9.  Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population.

Authors:  V De Las Heras; C De Andrés; N Téllez; M Tintoré
Journal:  Mult Scler       Date:  2007-07-10       Impact factor: 6.312

10.  Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

Authors:  Stella E Hughes; Tim Spelman; Orla M Gray; Cavit Boz; Maria Trojano; Alessandra Lugaresi; Guillermo Izquierdo; Pierre Duquette; Marc Girard; Francois Grand'Maison; Pierre Grammond; Celia Oreja-Guevara; Raymond Hupperts; Roberto Bergamaschi; Giorgio Giuliani; Jeannette Lechner-Scott; Michael Barnett; Maria Edite Rio; Vincent van Pesch; Maria Pia Amato; Gerardo Iuliano; Mark Slee; Freek Verheul; Edgardo Cristiano; Ricardo Fernández-Bolaños; Dieter Poehlau; Maria Laura Saladino; Norma Deri; Jose Cabrera-Gomez; Norbert Vella; Joseph Herbert; Eli Skromne; Aldo Savino; Cameron Shaw; Fraser Moore; Steve Vucic; Tatjana Petkovska-Boskova; Gavin McDonnell; Stanley Hawkins; Frank Kee; Helmut Butzkueven
Journal:  Mult Scler       Date:  2013-10-09       Impact factor: 6.312

View more
  14 in total

1.  Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding.

Authors:  Sigal Kaplan; Mikhail Zeygarnik; Tal Stern
Journal:  Drug Saf       Date:  2022-03-16       Impact factor: 5.228

2.  Natalizumab, Fingolimod and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis.

Authors:  Wei Zhen Yeh; Putu Ayu Widyastuti; Anneke Van der Walt; Jim Stankovich; Eva Havrdova; Dana Horakova; Karolina Vodehnalova; Serkan Ozakbas; Sara Eichau; Pierre Duquette; Tomas Kalincik; Francesco Patti; Cavit Boz; Murat Terzi; Bassem I Yamout; Jeannette Lechner-Scott; Patrizia Sola; Olga G Skibina; Michael Barnett; Marco Onofrj; Maria José Sá; Pamela Ann McCombe; Pierre Grammond; Radek Ampapa; Francois Grand'Maison; Roberto Bergamaschi; Daniele L A Spitaleri; Vincent Van Pesch; Elisabetta Cartechini; Suzanne Hodgkinson; Aysun Soysal; Albert Saiz; Melissa Gresle; Tomas Uher; Davide Maimone; Recai Turkoglu; Raymond Mm Hupperts; Maria Pia Amato; Franco Granella; Celia Oreja-Guevara; Ayse Altintas; Richard A Macdonell; Tamara Castillo-Trivino; Helmut Butzkueven; Raed Alroughani; Vilija G Jokubaitis
Journal:  Neurology       Date:  2021-04-20       Impact factor: 9.910

3.  Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS.

Authors:  Annika Anderson; Kristen M Krysko; Alice Rutatangwa; Tanya Krishnakumar; Chelsea Chen; William Rowles; Chao Zhao; Maria K Houtchens; Riley Bove
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-02-19

Review 4.  Early Aggressive Treatment Approaches for Multiple Sclerosis.

Authors:  Alexandra Simpson; Ellen M Mowry; Scott D Newsome
Journal:  Curr Treat Options Neurol       Date:  2021-05-15       Impact factor: 3.598

Review 5.  Switching treatments in clinically stable relapsing remitting multiple sclerosis patients planning for pregnancy.

Authors:  Lubna Almouzain; Fiona Stevenson; Declan Chard; Nur Abdul Rahman; Fiona Hamilton
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-03-19

Review 6.  Treatment of Women with Multiple Sclerosis Planning Pregnancy.

Authors:  Kristen M Krysko; Riley Bove; Ruth Dobson; Vilija Jokubaitis; Kerstin Hellwig
Journal:  Curr Treat Options Neurol       Date:  2021-03-30       Impact factor: 3.598

Review 7.  Updated Perspectives on the Challenges of Managing Multiple Sclerosis During Pregnancy.

Authors:  Ramón Villaverde-González
Journal:  Degener Neurol Neuromuscul Dis       Date:  2022-01-05

Review 8.  A systematic review of relapse rates during pregnancy and postpartum in patients with relapsing multiple sclerosis.

Authors:  Kerstin Hellwig; Elisabetta Verdun di Cantogno; Meritxell Sabidó
Journal:  Ther Adv Neurol Disord       Date:  2021-11-12       Impact factor: 6.570

Review 9.  Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies.

Authors:  Isabella Laura Simone; Carla Tortorella; Alma Ghirelli
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

Review 10.  MS, pregnancy and COVID-19.

Authors:  Charmaine Yam; Vilija Jokubaitis; Kerstin Hellwig; Ruth Dobson
Journal:  Mult Scler       Date:  2020-08-17       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.